Drug Trial News

RSS
Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

Multiple abstracts on QNEXA long-term clinical study to be presented at ADA 2011

Multiple abstracts on QNEXA long-term clinical study to be presented at ADA 2011

Endotis commences EP217609 Phase IIa study in patients undergoing open-heart surgery

Endotis commences EP217609 Phase IIa study in patients undergoing open-heart surgery

Oxford BioMedica reports RetinoStat progress in Phase I study against wet AMD

Oxford BioMedica reports RetinoStat progress in Phase I study against wet AMD

Positive topline results from Lipid Therapeutics LT-02 Phase IIb trial on ulcerative colitis

Positive topline results from Lipid Therapeutics LT-02 Phase IIb trial on ulcerative colitis

Medivir initiates TMC649128 phase Ib trial in chronic hepatitis C

Medivir initiates TMC649128 phase Ib trial in chronic hepatitis C

Pycnogenol, CoQ10 combination boost heart function

Pycnogenol, CoQ10 combination boost heart function

Results of African malaria vaccine trial expected later this year

Results of African malaria vaccine trial expected later this year

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint

Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint

Seaside Therapeutics commences STX209 Phase 2b study in autism spectrum disorders

Seaside Therapeutics commences STX209 Phase 2b study in autism spectrum disorders

DIA recognizes CAPRISA team for outstanding achievement in HIV prevention

DIA recognizes CAPRISA team for outstanding achievement in HIV prevention

Positive results from LCP-Tacro Phase III trial in stable kidney transplant recipients

Positive results from LCP-Tacro Phase III trial in stable kidney transplant recipients

Lorcaserin Phase 3 trial data on type 2 diabetes to be presented at ADA 2011

Lorcaserin Phase 3 trial data on type 2 diabetes to be presented at ADA 2011

Halozyme to present three data on Ultrafast Insulin programs at ADA 2011

Halozyme to present three data on Ultrafast Insulin programs at ADA 2011

Lilly, Boehringer Ingelheim to present new data from diabetes portfolio at ADA scientific sessions

Lilly, Boehringer Ingelheim to present new data from diabetes portfolio at ADA scientific sessions

New clinical trial to evaluate safety of tenofovir gel in breastfeeding, pregnant women

New clinical trial to evaluate safety of tenofovir gel in breastfeeding, pregnant women

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Initiation of ALD518/BMS-945429 Phase 2b clinical trial in RA triggers milestone payment to Alder

Initiation of ALD518/BMS-945429 Phase 2b clinical trial in RA triggers milestone payment to Alder

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.